Clinical Trial Update: TAK-438 - Safety, Blood Levels & Effects of Repeated Doses [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, pharmacokinetics (blood levels), and effects of repeated doses of TAK-438 (vonoprazan) in participants with erosive esoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• TAK-438 (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Erosive Esophagitis(EE), Gastroesophageal Reflux Disease (GERD) | Phase 1 | Status: COMPLETED